Announcement
Announcement under Regulation 30 (LODR)-Newspaper Publication 9 Sep - Newspaper advertisement regarding opening of the Special Window for transfer and dematerialisation (demat) of physical shares.
Source: Bse
Navin Fluorine International Limited (NAVINFLUOR)
Small CapChemicals stocks · Small cap · NSE
Navin Fluorine International Limited is a global provider of fluorochemical solutions, leveraging expertise, R&D, and manufacturing facilities. It offers a diversified portfolio across Specialty Chemicals, High Performance Products (HPP), and Contract Development and Manufacturing Organization (CDMO) segments.
Data qualityFresh enough for analysisQuote updated 19 Oct, 03:31 pm ISTDetails
Quote19 Oct, 03:31 pm IST
Base fundamentals16 Oct 2026 · screener
Latest result05 Aug, 09:55 pm IST
Score20 Oct, 04:30 am IST · v4.3-runtime-valuation
Tags15 Aug 2026
Coverage13/14 · 93%
Valuation2026-07-20 · Rf 6.8% · Chemicals P/E 33.1 (n=45)
Technical timing lens
Trend score and candlestick chart
49NeutralSMA20 -1.4% / mo · MACD − · sector -4.2pp vs Nifty 500 (3M)
Stock trend: 51
Sector RS: 46
Sector 3M: -9.8% vs Nifty 500 -5.6%
Chemicals FPI tailwindNot confirmed
Latest mapped FPI equity flow was not positive. View sector evidence
Technical chart
NAVINFLUORD candles · FIT view+26.4%Latest close ₹8152.50 on 2026-10-19
Bar
-0.2%
RSI
42
MACD hist
-32.03
52W pos
80%
2026-10-19O ₹8167.00H ₹8198.00L ₹8111.00C ₹8152.50Vol 39,470 sh
Up bar
Down bar
EMA 20
EMA 50
Volume + 20D avg
Result date
RSI(14)
MACD / signal
Market context
Relative performance and chart statistics
Adjusted completed-session prices, rebased to 100
NAVINFLUORNifty ChemicalsNifty 500
- NAVINFLUOR
- +3.7%
- Nifty 500
- -5.6%
- Nifty Chemicals
- -8.5%
- Vs Nifty 500
- +9.3 pp
Chart stats
19 Oct 2026- From 52W high
- -8.9%
- 52W range position
- 82%
- ATR (14)
- 2.7%
- Volume vs 20D
- 0.37x
- Avg traded value
- ₹79.5 Cr
- 20D price channel
- ₹8,035 - ₹8,650
₹8,949.5
₹4,569.1 - ₹8,949.5
₹217
Latest completed session
20-session average
23.6% annualized volatility
Research snapshot
What the evidence says now
Mixed fundamentals, management evidence is still limited to a financial-only Trust Lite signal, price trend is neutral, and recent execution is consistent.
Suggested next step
Research, do not rush
The evidence is not strongly aligned. Compare peers and wait for a cleaner setup.
U-Score
Legacy · FAIR VALUE46
Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.
Latest result
Excellent100
Revenue +44.1% · PAT +107.7% YoY
Technical
Neutral49
Price trend and sector-relative-strength timing.
Valuation
Legacy model-17.6%
Legacy margin-of-safety estimate; the revised evidence label remains in shadow validation.
Trust
Limited evidence83
Financial-only signal; management claim evidence is not sufficient yet.
Financials
Fundamentals, quarterly history, margins, returns and balance-sheet evidence
Financials
Fundamentals, quarterly history, margins, returns and balance-sheet evidence
Latest result
Quarter ended 30 Jun 2026
Excellent · 100/100Rev +44% YoY · PAT +108% YoY · margin expansion · +11% QoQ · operating leverage
Filed 05 Aug 2026
Open results browser →| Metric | This quarter | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹1,045 Cr | +44.1% | +11.4% |
| EBITDA | ₹357 Cr | +72.5% | +11.2% |
| Operating margin | 34.0% | +500 bps | +0 bps |
| PAT | ₹243 Cr | +107.7% | +14.1% |
| PAT margin | 23.3% | +711 bps | +54 bps |
NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.
Fundamentals
Valuation
- P/E
- 52.50
- P/B
- 10.50
- EV/EBITDA
- 31.01
- Market Cap
- 41771.00Cr
Profitability
- ROE
- 19.60%
- ROCE
- 21.00%
- ROA
- 12.38%
- Dividend Y
- 0.18%
Growth (CAGR)
- Revenue 5Y
- 23.00%
- EPS 5Y
- 21.00%
- Revenue 3Y
- 17.00%
- EPS 3Y
- 21.00%
Balance Sheet
- Debt/Equity
- 0.32
- Interest Coverage
- 10.27×
- Altman Z
- 8.30
- Book Value
- 775.00
Cash Flow
- FCF Yield
- —
- FCF Positive Y
- 7/5
- OCF
- 894.00 Cr
- EPS TTM
- 154.05
Shareholding
- Promoter Hold
- 27.08%
- Promoter Pledge
- 0.00%
- Momentum 52W
- 80%
Financial History
Updated 20/10/2026
Revenue
₹ CrLatest: 1,045+11.4% vs prev
Net Profit
₹ CrLatest: 243+14.1% vs prev
ROE is shown only in the Annual view — quarterly equity data isn't published.
Technicals
Trend interpretation, Stage 2, relative strength, volume and indicator evidence
Technicals
Trend interpretation, Stage 2, relative strength, volume and indicator evidence
Daily technical trend read
Bearish setupTrend is weak — long-term uptrend intact. RSI 42.
- Price above SMA200 (long-term uptrend) but mid-term MAs not aligned.
- SMA20 falling (~1.4% over last month) — short-term momentum negative.
- RSI(14) at 42 — falling, no extreme reading.
- MACD below signal, histogram expanding negatively — bearish momentum building.
- 9% off 52W high · 67% above 52W low.
Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.
Nifty 500 leadership
Relative Strength & Trend Stage
95
RS percentile
Stage 2 UptrendEstablished S2
1M return
-5.1%
3M return
+3.7%
6M return
+30.1%
1Y return
+63.1%
RS 1D
+1
RS 20D
0
Sector rank
#13
Industry rank
#15
Stage evidence
- Price is 9.0% above the 30-week proxy.
- The 50-DMA is above the 30-week proxy and its slope is rising +3.7%.
- Both 3-month and 6-month returns are positive.
50-DMA
price below
200-DMA
price above
S2 entered
08 Apr 2026
S2 age
137 trading sessions
Sector
neutral
Industry
neutral
Relative-strength line vs Nifty 500 (base 100)
262 observations
19 Oct 2026Value 183.7+0.86%
RS vs Nifty 500184
Valuation & peers
U-Score 46 · legacy U-Score band FAIR VALUE · valuation evidence and comparable companies
Valuation & peers
U-Score 46 · legacy U-Score band FAIR VALUE · valuation evidence and comparable companies
Premium Compounder
Fundamental score breakdown
U band · FAIR VALUEValuation0/30
Growth14/25
Quality16/20
Balance Sheet7/15
Cash Flow4/10
Piotroski
8/9 (+5)
Penalties
0
Raw sum
46
Why this score?
Top U-Score contributors and drags from the latest stored fundamentals.
46/100 · legacy band FAIR VALUE
Positive drivers
- Piotroski is strong at 8/9.
- Quality contributes 16/20 to the score.
- Growth contributes 14/25 to the score.
Main drags
- Fair-value margin of safety is negative at -17.6%.
- Valuation is weaker at 0/30; verify the latest quarterly trend.
- Cash flow is weaker at 4/10; verify the latest quarterly trend.
Sector valuation model
Cyclical valuation: normalized earnings, not just trailing PE
Cyclical companies can look cheapest near peak profits, so IndiaPulse flags value-trap risk separately.
Primary lens
Mid-cycle PE/EV/EBITDA using multi-year average margins or earnings.
Secondary checks
Current margin versus 5-year average, balance sheet strength, commodity cycle.
Main risk check
A low trailing PE may mean peak-cycle earnings, not true cheapness.
PE
52.5
PB
10.5
EV/EBITDA
31.0
ROE
19.6%
ROCE
21.0%
FCF Yield
—
Debt/Equity
0.3
MoS
-17.6%
Cyclical/value-trap warning
This sector can look cheap when profits are temporarily high. Check mid-cycle margins/earnings before relying on trailing PE.
Score movement
Stored run vs live recompute
This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.
Stored run: 20 Oct 2026
v4.3-runtime-valuation
Final score
46
Previous: 46
Legacy U-Score band
FAIR VALUE
Previous: FAIR VALUE
Margin of safety
-17.6%
Previous: -17.6%
Score history
12 stored score snapshots. Latest stored move: +0 points.
20 Oct 2026
v4.3-runtime-valuation
46
46
46
46
46
46
46
46
46
46
46
46
Factor attribution
No pillar movement versus the latest stored run. Historical score trend will appear after snapshot storage is enabled.
Modelled fair value
Graham Number
₹1,638.98
-397.4% MoS
Growth-justified P/E
45.0
Growth-justified Value
₹6,932.25
-17.6% MoS
PEG
2.50
Comparable companies
Peers
Business-comparable peers in Chemicals — ranked by industry, sub-sector, theme-tag overlap, market cap, and U-Score similarity. Green cells mark the best available peer metric in this table.
Ticker
Name
Why peer
Score
PE
ROE
MoS
Verdict
HSCL
Small
Himadri Speciality Chemical Limited
Specialty Chemicals
match 165
55
39.0
17.8%
+21%
FAIR VALUE
AARTIIND
Small
Aarti Industries Limited
Specialty Chemicals
match 164
20
35.0
7.1%
-538%
OVERVALUED
FLUOROCHEM
Large
Gujarat Fluorochemicals Limited
Specialty Chemicals
match 159
36
82.2
7.8%
-80%
WATCHLIST
SRF
Mid
SRF Limited
Specialty Chemicals
match 158
42
32.2
14.3%
-7%
WATCHLIST
AETHER
Micro
Aether Industries Limited
Specialty Chemicals
match 156
29
94.9
9.7%
-175%
OVERVALUED
Business, management & trust
Growth engines, risks, management commitments and evidence-backed delivery
Business, management & trust
Growth engines, risks, management commitments and evidence-backed delivery
Business and thesis
Where growth can come from, and what can break the case
Thesis intactReviewed 2026-06-07T07:13:06.034Z
Management commentary snapshot
Q4FY26 consolidated sales grew 34% YoY and 5% QoQ to Rs. 937.7 Crs, with Operating EBITDA up 80% YoY and 4% QoQ to Rs. 321.2 Crs. Operating EBITDA margin expanded 875 bps YoY to 34.2%. FY26 saw 41% YoY sales growth and 103% YoY Operating EBITDA growth.
The company delivered robust Q4 and FY26 results, marked by significant revenue and EBITDA growth, alongside substantial margin expansion. Ongoing strategic capex projects across HFC, MPP, and Advanced Materials, coupled with strong order visibility in Specialty Chemicals and CDMO, support continued growth.
Growth engines
Specialty CDMO Momentum
Strong momentum continues with a balanced portfolio of late/commercial and early-stage molecules, increasing footprint across therapeutic areas like Oncology, Respiratory, Cardiovascular, Neurology, and Animal health.
HPP Volume & Realization
Revenue growth in HPP led by improved realizations and higher volumes, supported by a constructive pricing environment for HFC.
Specialty Chemicals Pipeline
Product pipeline remains strong, with meaningful scale-up across existing molecules and a strong line-up of new launches, supported by strong order visibility.
Advanced Materials Expansion
Expanding footprint in emerging and innovative Advanced Materials products, with initial commercial capacity for liquid cooling products.
Capacity and execution
HFC MPP Capacity
Additional HFC capacity equivalent to up to 15,000 MTPA of R32, with a capex of Rs. 236.5 Crs, expected to be commissioned by Q3FY27, with peak revenue potential of Rs. 600-825 Crs per annum.
Dahej MPP De-bottlenecking
De-bottlenecking MPP capacity at Dahej with a capex of Rs. 75 Crs, targeted for commissioning by Q3FY27, to support a new molecule for a global innovator with peak revenue potential of Rs. 140-160 Crs per annum.
Advanced Materials Capacity
Initial commercial capacity for manufacturing an innovative liquid cooling product with a capex of Rs. 120 Crs (35% customer funded), targeted for commissioning by Q1FY27.
AHF Capex
AHF capex has been commissioned, and commercial supply has started.
Tailwinds
HFC Demand-Supply
Constructive global demand-supply environment for HFCs driven by transition to low GWP gases and increasing RAC and blends demand in India and export markets.
Strong Order Visibility
Sustained growth in Specialty Chemicals supported by strong order visibility.
CDMO Outlook
Strong outlook for European CDMO MSA into FY27 and beyond, with successful completion of validation and commercial supplies started from cGMP4.
Backward Integration
Backward integration of key products to basic feedstock offers a China-free alternative with minimal import dependency.
Management accountability
What management said, and what results must prove
Issuer guidance and extracted claims are tracked against later reported outcomes. Treat these as management statements, not IndiaPulse forecasts.
Analyst reading lens
Compare BOTH
YoY comparison is crucial for assessing overall growth and margin expansion trends. QoQ comparison provides insight into sequential momentum and operational efficiency in a dynamic market.
Sector KPIs management disclosed
Revenue Growth
Q4FY26 Sales: Rs. 937.7 Crs (+34% Y-o-Y, +5% Q-o-Q). FY26 Sales: Rs. 3313.9 Crs (+41% Y-o-Y).
Operating EBITDA Margin
Q4FY26: 34.2% (+875 bps Y-o-Y, -22 bps Q-o-Q). FY26: 32.6% (+992 bps Y-o-Y).
ROE
FY26: 20.1% (+8.6% Y-o-Y from 11.5% in FY25).
ROCE
FY26: 21.0% (+9.5% Y-o-Y from 11.5% in FY25).
Management forward view
3P Approach
Management focuses on a '3P approach' – Product, Platform, and Partnerships – to build capacities, scalable platforms, and nurture long-term relationships.
R&D and Innovation
Strong R&D engagement supports co-development initiatives, accelerating innovation and customized solutions, with a total R&D spend of Rs. 54.69 Crs in FY25.
ESG Commitment
Committed to ESG, undertaking environmentally friendly initiatives like waste heat recovery, increased solar electricity capacity, water recycling, and plastic waste management across facilities.
Strategic Partnerships
Forging multiyear partnerships to integrate within the global supply chain, positioning alongside industry majors and harnessing their expertise and resources.
Thesis monitor
Numbers and claims to verify in the next filings
| Checkpoint | Current evidence | What to verify next |
|---|---|---|
| HFC Capacity Commissioning | Q3FY27 | Monitor successful commissioning and ramp-up of additional HFC capacity and its contribution to revenue. |
| MPP De-bottlenecking | Q3FY27 | Track commissioning of Dahej MPP de-bottlenecking and revenue generation from the new molecule for the global innovator. |
| Advanced Materials Ramp-up | Q1FY27 | Observe the commissioning and initial commercial adoption of the innovative liquid cooling product in Advanced Materials. |
| Chemours Project Completion | Q1FY27 | Verify the timely completion of the Chemours project and its contribution to Specialty Chemicals segment. |
Verification checkpoints are IndiaPulse research interpretation, not investment advice.
Trust Score
83Limited evidence · low confidenceTrust Lite
Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.
Limited evidence: Claim history is still being built. It ranks around the 95th percentile of the scored universe and 94th percentile within Chemicals. No major sub-score weakness stands out.
This is a financial-behaviour screen, not a claim-tested management reliability verdict.
Computed 20 Oct 2026
management-trust-v1
229 docs text-extracted · 59 concalls text-extracted
Score band
Limited evidence
Financial behaviour is scored, but management claims do not yet have enough outcome checks.
Relative rank
95th percentile
overall median 67 · Chemicals: 94th pctile, median 73 · Small: 96th pctile, median 66
Evidence depth
Financial-only
229 documents have extracted text, but claim history is not strong enough yet.
Claim delivery
Outcome history still building
0 claims extracted · No contradicted claim yet
How to read this Trust Score
Limited evidence · low confidenceWhat it measures
Reliability of management and financial delivery, using financial behaviour only.
Confidence
Treat this as an early read until more concalls and outcomes are matched.
Investor use
Can support position sizing if valuation and trend also agree.
Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.
Forensic breakdown
Read low sub-scores as due-diligence warnings, not automatic sell signals.
Promoter
78
strong · holding, pledge, alignment
Cash flow
67
acceptable · profit to cash conversion
Balance sheet
89
strong · leverage and solvency
Discipline
98
strong · capital discipline
Results
87
strong · quarterly consistency
Trust positives
- ▸Promoter pledge is zero.
- ▸7 years of positive FCF.
- ▸ROCE is 21%.
- ▸4/4 latest quarters had positive YoY revenue growth.
Trust risks
- ▸No major Trust Lite risk flags.
Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.
Continue researching Navin Fluorine International Limited
Important announcements & filings
Latest exchange and company disclosures found within the past two years.
Open source ↗
Announcement
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 7 Sep
Source: Bse
Announcement
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 7 Sep
Source: Bse
Announcement
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS 26 Aug - Allotment of Equity Shares under Employees'' Stock Option Scheme 2017
Source: Bse
Credit rating
Announcement under Regulation 30 (LODR)-Credit Rating 18 Aug - Crisil ESG assigned Navin Fluorine ESG rating of 62 and Core ESG 66.
Source: Bse
Announcement
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 17 Aug
Source: Bse
Announcement
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS 20 Jul - Allotment of Equity shares under Employees'' Stock Option Scheme 2007 and 2017
Source: Bse
Announcement
Announcement under Regulation 30 (LODR)-Newspaper Publication 17 Jul - Disclosure under Regulation 30 of SEBI (Listing and Disclosure Requirements) Regulations.
Source: Bse
Announcement
Announcement under Regulation 30 (LODR)-Newspaper Publication 17 Jul - Publication of Notice for attention of the shareholders of the Company in respect of transfer of shares to the Investor Education and Protection Fund
Source: Bse
Announcement
Announcement under Regulation 30 (LODR)-Newspaper Publication 17 Jul - Newspaper advertisement regarding opening of the Special Window for transfer and dematerialization (demat) of physical shares.
Source: Bse
Announcement
Announcement under Regulation 30 (LODR)-Newspaper Publication 16 Jul
Source: Bse
Annual report
Reg. 34 (1) Annual Report. 15 Jul
Source: Bse
All information is for study purposes only. For investment decisions, consult your financial advisor. See Playbook for methodology.